ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,216Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 97

$570K Total Retail Price of All Prescriptions

Rank: 23 out of 97

684 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 684 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 12,430 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LISINOPRIL 757 728 1 4
SIMVASTATIN 743 670 2 2
LEVOTHYROXINE SODIUM 707 658 3 1
AMLODIPINE BESYLATE 528 497 4 6
OMEPRAZOLE 423 390 5 5
HYDROCHLOROTHIAZIDE 417 410 6 9
METOPROLOL TARTRATE 357 349 7 7
WARFARIN SODIUM 353 328 8 11
FUROSEMIDE 346 312 9 3
METOPROLOL SUCCINATE 324 306 10 8
ATORVASTATIN CALCIUM 310 310 11 14
POTASSIUM CHLORIDE 293 289 12 10
METFORMIN HCL 281 260 13 12
CITALOPRAM HBR 256 239 14 20
PRAVASTATIN SODIUM 248 235 15 28
ALENDRONATE SODIUM 234 233 16 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 234 211 16 36
ATENOLOL 185 183 18 15
DIGOXIN 171 171 19 26
CARVEDILOL 162 140 20 25
CRESTOR 160 160 21 29
DOXAZOSIN MESYLATE 158 158 22 45
TAMSULOSIN HCL 137 137 23 31
DONEPEZIL HCL 132 132 24 24
LOVASTATIN 129 128 25 62
HYDROCODONE-ACETAMINOPHEN 126 122 S3 26 17
DILTIAZEM 24HR CD 124 122 27 73
LOSARTAN POTASSIUM 119 119 28 13
NAMENDA 118 118 29 38
DILTIAZEM 24HR ER 110 110 30 69
ISOSORBIDE MONONITRATE ER 107 107 31 27
FINASTERIDE 95 95 32 58
VYTORIN 90 80 33 127
ZOLPIDEM TARTRATE 90 87 33 32
JANUVIA 90 87 33 59
ALLOPURINOL 88 87 36 22
ADVAIR DISKUS 85 85 37 40
GABAPENTIN 72 57 38 18
NIFEDIPINE ER 71 67 39 118
DIOVAN 69 69 40 44
ZETIA 66 57 41 51
SERTRALINE HCL 66 61 41 16
GLYBURIDE 65 56 R 43 75
CLOPIDOGREL 62 62 44 34
LIPITOR 62 62 44 91
PREDNISONE 61 60 46 23
GLIPIZIDE 61 59 46 78
JANTOVEN 58 58 48 37
CELEBREX 57 57 49 95
RANITIDINE HCL 56 40 50 67
LANTUS SOLOSTAR 56 53 50 41
GLIMEPIRIDE 55 55 52 39
AVODART 55 55 52 94
TRAMADOL HCL 54 46 54 21
FELODIPINE ER 52 52 55 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.